GlassScriptPhysician profile
Grace D Pascual
NPI 1942315544
$8,094.04
in general payments reported to CMS, 2019-2025
27 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $160 · 2021: $1,892 · 2022: $1,002 · 2023: $1,807 · 2024: $673 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000 · Honoraria: $893 · Education: $117 · Travel and Lodging: $19.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.54 |
| Honoraria | $893.00 |
| Education | $116.83 |
| Travel and Lodging | $19.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,960.12 | 2021-2023 | Acumed |
| Osteomed LLC | $1,534.15 | 2019 | |
| Horizon Therapeutics Plc | $1,184.46 | 2019-2023 | Krystexxa |
| Stryker Corporation | $790.51 | 2022-2023 | Omega |
| Abbvie INC. | $405.59 | 2021-2025 | |
| Orthofix Medical, INC. | $320.24 | 2023-2025 | Physio-Stim, Accelstim |
| Smith+Nephew, INC. | $257.60 | 2019-2023 | Versajet |
| Allergan, INC. | $205.15 | 2019-2020 | |
| Amgen INC. | $192.65 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $153.56 | 2019 | |
| Kerecis Limited | $116.83 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $110.39 | 2023 | Absolute Pro |
| Kowa Pharmaceuticals America, INC. | $93.02 | 2023 | Seglentis, Livalo |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Anika Therapeutics, INC. | $87.50 | 2024 | Toe Motion |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $86.73 | 2019-2023 | V.A.C. Dermatac |
| Organogenesis INC. | $82.77 | 2024-2025 | Apligraf |
| Solventum Corporation | $82.32 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Depuy Synthes Sales INC. | $79.54 | 2024-2025 | Motoband |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.22 | 2022 | |
| Medtronic, INC. | $53.45 | 2025 | Inceptiv |
| Averitas Pharma INC. | $44.33 | 2024 | Qutenza |
| Trimed, INC. | $23.13 | 2025 | |
| Trice Medical, INC. | $21.24 | 2024 | |
| Bioventus LLC | $20.26 | 2020 | |
| Convatec INC. | $18.58 | 2024 | |
| Amniox Medical, INC. | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Pascual listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.